ClinConnect ClinConnect Logo
Search / Trial NCT00002455

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

Launched by CENTRO ONCOLOGICO DE EXCELENCIA · Jan 26, 2003

Trial Information

Current as of July 15, 2025

Unknown status

Keywords

Stage I Colon Cancer Stage Ii Colon Cancer Stage Iii Colon Cancer Stage I Breast Cancer Stage Ii Breast Cancer Stage Iiia Breast Cancer Recurrent Breast Cancer Recurrent Colon Cancer Stage I Melanoma Stage Ii Melanoma Stage Iii Melanoma Recurrent Melanoma

ClinConnect Summary

OBJECTIVES:

* Determine the survival of patients with colon cancer, breast cancer, or melanoma with minimal residual disease after surgical resection treated with maintenance immunotherapy using Corynebacterium granulosum P40.
* Determine leucocyte adherence inhibition, an indication of metastases, over time in patients treated with this regimen.

OUTLINE: This is a multicenter study. Patients are stratified by center and are matched with case-controls by disease type and stage.

Beginning 2 weeks after surgical resection, patients receive Corynebacterium granulosum P40 subcutaneously week...

Gender

ALL

Eligibility criteria

  • DISEASE CHARACTERISTICS:
  • Diagnosis of colon cancer, breast cancer, or melanoma with minimal residual disease (at least 90% of tumor mass resected) after surgical resection
  • * Hormone receptor status:
  • Not specified
  • PATIENT CHARACTERISTICS:
  • Age:
  • 20 to 80
  • Sex:
  • Not specified
  • Menopausal status:
  • Not specified
  • Performance status:
  • Not specified
  • Life expectancy:
  • Not specified
  • Hematopoietic:
  • Not specified
  • Hepatic:
  • Not specified
  • Renal:
  • Not specified
  • PRIOR CONCURRENT THERAPY:
  • Biologic therapy
  • Not specified
  • Chemotherapy
  • Not specified
  • Endocrine therapy
  • Not specified
  • Radiotherapy
  • Not specified
  • Surgery
  • See Disease Characteristics

About Centro Oncologico De Excelencia

Centro Oncológico de Excelencia is a leading clinical trial sponsor dedicated to advancing cancer research and treatment. With a commitment to innovative therapies and patient-centered care, the center collaborates with top-tier medical institutions and researchers to conduct rigorous clinical trials. Its multidisciplinary team of experts focuses on developing cutting-edge oncology solutions, ensuring adherence to the highest ethical and regulatory standards. By fostering collaboration and leveraging the latest scientific advancements, Centro Oncológico de Excelencia aims to improve outcomes for cancer patients and contribute significantly to the global fight against cancer.

Locations

Gonnet, Buenos Aires, Argentina

Patients applied

0 patients applied

Trial Officials

Hugo Omar De Carli, MD

Study Chair

Centro Oncologico de Excelencia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials